Pacemaker, Artificial

• 

  Subject Areas on Research

  • 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 
  • 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. 
  • 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. 
  • A Minimally Invasive Approach for Placing Sew-On Epicardial Leads in the Child. 
  • A Predictive Model for the Long-Term Electrical Performance of a Leadless Transcatheter Pacemaker. 
  • ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. 
  • ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. 
  • ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. 
  • Adverse effects of first-degree AV-block in patients with sinus node dysfunction: data from the mode selection trial. 
  • Amino acid alterations in fibronectin binding protein A (FnBPA) and bacterial genotype are associated with cardiac device related infection in Staphylococcus aureus bacteraemia. 
  • Analysis of Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement. 
  • Analysis of secondary pauses following termination of rapid atrial pacing in man. 
  • Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery. 
  • Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices. 
  • Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme. 
  • Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction. 
  • Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST). 
  • Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices. 
  • Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results From the MARVEL 2 Study. 
  • Attempted lead extraction in low-risk patients without surgical backup: Progress or peril? 
  • Autopsy findings with permanent pervenous pacemakers. 
  • Behavior of AV synchrony pacing mode in a leadless pacemaker during variable AV conduction and arrhythmias. 
  • Body image changes associated with dual-chamber pacemaker insertion in women. 
  • CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation. 
  • Calcific valvular aortic stenosis with and without mitral anular calcium. 
  • Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis. 
  • Cardiac pacing for sinus-node dysfunction. 
  • Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients. 
  • Cardiac resynchronization therapy in heart failure patients: an update. 
  • Cardiac resynchronization therapy: Part 1--issues before device implantation. 
  • Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. 
  • Cardiac-resynchronization therapy for the prevention of heart-failure events. 
  • Cardiothoracic Morphology Measures in Heart Failure Patients to Inform Device Designs. 
  • Care of the patient with cardiovascular disease undergoing general surgery. 
  • Case 1-1982: Atrioventricular heart block. 
  • Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. 
  • Clinical and quality of life comparison of accelerometer, piezoelectric crystal, and blended sensors in DDDR-paced patients with sinus node dysfunction in the mode selection trial (MOST). 
  • Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. 
  • Collision of excitation waves in the dog Purkinje system. Extracellular identification. 
  • Comparison of Fontan survivors with and without pacemakers: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. 
  • Complications arising after implantation of DDD pacemakers: the MOST experience. 
  • Concealed mechanical bradycardia: an indication for permanent pacemaker implantation. 
  • Construction of a very high-density extracellular electrode array. 
  • Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker. 
  • Coronary sinus atrial pacing: radiographic considerations. 
  • Correlation between AV synchrony and device collected AM-VP sequence counter in atrioventricular synchronous leadless pacemakers: A real-world assessment. 
  • Counterclockwise exit of cardiac pacemaker leads: sign of pulse-generator flip. 
  • Cross communication. Avoiding device interference in pacemakers and ICDs. 
  • Death in patients with permanent pacemakers for sick sinus syndrome. 
  • Determination of leakage currents in medical equipment. 
  • Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker. 
  • Device therapy in heart failure patients with chronic kidney disease. 
  • Dexmedetomidine related cardiac arrest in a patient with permanent pacemaker; a cautionary tale. 
  • Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. 
  • Dissociation rate constants of human fibronectin binding to fibronectin-binding proteins on living Staphylococcus aureus isolated from clinical patients. 
  • ELECTRICAL HAZARDS ASSOCIATED WITH CARDIAC PACEMAKING. 
  • Effect of pacing site on ventricular fibrillation initiation by shocks during the vulnerable period. 
  • Electrical hazards and cardiovascular function. 
  • Electrical stimulation of the conus medullaris to control bladder emptying in paraplegia: a ten-year review. 
  • Electromagnetic Interference with Protocolized Electrosurgery Dispersive Electrode Positioning in Patients with Implantable Cardioverter Defibrillators. 
  • Electromechanical associations. 
  • Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. 
  • Emergency room and inpatient use after cardiac pacemaker implantation. 
  • Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the fontan procedure. 
  • Endovascular transcatheter aortic valve implantation: an evolving standard. 
  • Epidemiology, evaluation, and management of conduction disturbances after transcatheter aortic valve replacement. 
  • European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). 
  • Evaluation of several methods for computing stroke volume from central aortic pressure. 
  • Exercise training and pacing status in patients with heart failure: results from HF-ACTION. 
  • Extraction of chronically implanted coronary sinus leads active fixation vs passive fixation leads. 
  • Glocal clinical registries: pacemaker registry design and implementation for global and local integration--methodology and case study. 
  • Guidance of cardiac pacemaker leads using real time 3D ultrasound: feasibility studies. 
  • HAZARDS OF ELECTRIC SHOCK IN CARDIOLOGY. 
  • HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs). 
  • HRS/ACCF expert consensus statement on pacemaker device and mode selection. 
  • HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons. 
  • Hands on: How to approach patients undergoing lead extraction. 
  • Have the results of randomized clinical trials of pacing altered the practice of cardiac pacing? 
  • Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. 
  • Hemodynamic consequences of right ventricular isolation: the contribution of the right ventricular free wall to cardiac performance. 
  • High prevalence of symptomatic bradyarrhythmias due to atrioventricular node-fascicular and sinus node-atrial disease in patients with mitral anular calcification. 
  • Imaging of the intensive care unit patient. 
  • Immediate and remote prognostic significance of fascicular block during acute myocardial infarction. 
  • Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis. 
  • Impact of peer review in reduction of permanent pacemaker implantations. 
  • Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). 
  • Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment. 
  • Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction. 
  • Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation. 
  • In response. 
  • Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study. 
  • Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. 
  • Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. 
  • Indications for pacing in the treatment of bradyarrhythmias. Report of an independent study group. 
  • Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure. 
  • Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. 
  • Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. 
  • Laser lead extraction in congenital heart disease: a case-controlled study. 
  • Laser-assisted extraction of pacemaker and defibrillator leads: the role of the cardiac surgeon. 
  • Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. 
  • Leadless Pacing-Uncertainties Remain About Safety and Efficacy-Reply. 
  • Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry. 
  • Leadless pacemaker implant with concomitant atrioventricular node ablation: Experience with the Micra transcatheter pacemaker. 
  • Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry. 
  • Leadless pacemaker implantation after lead extraction for cardiac implanted electronic device infection. 
  • Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up. 
  • Localization of pacing and defibrillator leads using standard x-ray views is frequently inaccurate and is not reproducible. 
  • Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial. 
  • Malposition of a pacemaker lead. 
  • Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model. 
  • Measuring left ventricular mechanical dyssynchrony from ECG-gated SPECT myocardial perfusion imaging. 
  • Minitransseptal versus left atrial approach to the mitral valve: a comparison of outcomes. 
  • Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker. 
  • New Pacemaker Implantation After Alcohol Septal Ablation: How Sharp Is the Double-Edged Sword? 
  • New medical technologies in a cost containment environment: Implantable antitachyarrhythmia devices. 
  • Novel approaches to clinical trials: device-related infections. 
  • Operational use and patient monitoring in a multiplace hyperbaric chamber. 
  • Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. 
  • Origin of body surface QRS and T wave potentials from epicardial potential distributions in the intact chimpanzee. 
  • Outcomes Associated With Extraction Versus Capping and Abandoning Pacing and Defibrillator Leads. 
  • Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims. 
  • Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). 
  • Pacemaker contact dermatitis: clinical and histopathologic description. 
  • Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). 
  • Pacemaker lead prolapse through the pulmonary valve in children. 
  • Pacemaker therapy in isolated congenital complete atrioventricular block. 
  • Pacemaker-induced transient asynchrony suppresses heart failure progression. 
  • Pacemakers are for living--not for fiddling! 
  • Paroxysmal high-grade atrioventricular block and syncope in a previously healthy child: what is the mechanism? 
  • Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. 
  • Percutaneous interventions in high-risk patients following Mustard repair of transposition of the great arteries. 
  • Perioperative management of cardiovascular implantable electronic devices: what every anesthesiologist needs to know. 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry. 
  • Permanently implantable diagnostic computerized devices: where is the regulatory rar? 
  • Persistent repetitive supraventricular tachycardia. 
  • Pitfalls in programming: The HV and VH intervals in his bundle pacing. 
  • Polymorphisms in fibronectin binding protein A of Staphylococcus aureus are associated with infection of cardiovascular devices. 
  • Potential additional indicators for pacemaker requirement in isolated congenital atrioventricular block. 
  • Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion. 
  • Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation. 
  • Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. 
  • Predictors of atrial mechanical sensing and atrioventricular synchrony with a leadless ventricular pacemaker: Results from the MARVEL 2 Study. 
  • Predictors of stroke in patients paced for sick sinus syndrome. 
  • Preprocedural computed tomography before cardiac implanted electronic device lead extraction: Indication, technique, and approach to interpretation. 
  • Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. 
  • Procainamide-induced sinus node dysfunction in patients with chronic renal failure. 
  • Process Improvement Initiative for the Perioperative Management of Patients With a Cardiovascular Implantable Electronic Device. 
  • Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation. 
  • Prolonged sinoatrial pauses. 
  • Prospective Evaluation of the Correlation Between Gated Cardiac Computed Tomography Detected Vascular Fibrosis and Ease of Transvenous Lead Extraction. 
  • Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunction. 
  • Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. 
  • Real-time 3D color flow Doppler for guidance of vibrating interventional devices. 
  • Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease. 
  • Regulation Without Representation: Cardiac Device Patient Knowledge and Attitudes About the FDA Regulatory Process. 
  • Relationship between atrial tachyarrhythmias and symptoms. 
  • Remote monitoring of cardiac implantable electronic devices (CIED). 
  • Reply: Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement. 
  • Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation. 
  • Revisiting Twiddler Syndrome. 
  • Right atrial appendage pacing: radiographic considerations. 
  • Significance of high degree atrioventricular block in acute posterior myocardial infarction. The importance of clinical setting and mechanism of block. 
  • Sinus node disease. 
  • Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome. 
  • Spread of excitation from the atrium into thoracic veins in human beings and dogs. 
  • Standardized Perioperative Note to Improve Perioperative Management of Patients With Cardiac Implantable Electronic Devices. 
  • Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. 
  • Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. 
  • Sudden death and pacemakers. 
  • Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. 
  • Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort. 
  • Swallow syncope. 
  • The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: executive summary this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). 
  • The ICU chest film. Cardiopulmonary monitoring and assist devices. 
  • The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. 
  • The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: insights from the Mode Selection Trial (MOST). 
  • The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. 
  • The epicardial screw-on electrode. An analysis of 114 consecutive patients with complete one-year follow-up. 
  • The paradox of innovation with leadless pacing. 
  • The radiology of cardiac pacemakers. 
  • Thresholds of fibrillating leakage currents along intracardiac catheters: an experimental study. 
  • Transcatheter Leadless Pacemaker Implantation for Complete Heart Block Following CoreValve Transcatheter Aortic Valve Replacement. 
  • Transient reversal of bifascicular block during acute myocardial infarction with reperfusion therapy: a word of caution. 
  • Transvenous pacemaker placement: left lateral decubitus position and wireless digital radiography. 
  • Ultrasound accelerated catheter directed thrombolysis for pulmonary embolus and right heart thrombus secondary to transvenous pacing wires. 
  • Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. 
  • Use of Preprocedural MDCT for Cardiac Implantable Electric Device Lead Extraction: Frequency of Findings That Change Management. 
  • Use of cardiac implantable electronic devices in older adults with cognitive impairment. 
  • Use of cardiac resynchronization therapy in patients hospitalized with heart failure. 
  • Use of vagal nerve stimulation as a treatment for refractory epilepsy in dogs. 
  • VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers. 
  • Venoplasty and Stenting. 
  • Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. 
  • Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. 
  • Why the Authors Use Cardiac Resynchronization Therapy with Defibrillators. 
  • Y2K: effects on pacemaker and implantable defibrillator programmers. 
• 

  Keywords of People

  • Carboni, Michael Paul, Associate Professor of Pediatrics, Pediatrics, Cardiology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery